Idelalisib as upfront therapy for CLL caused an early hepatotoxicity in a subset of primarily younger patients with
Home / Resource Library / Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity